Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer
Status:
Recruiting
Trial end date:
2024-02-10
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy and safety of S-1 plus Oxaliplatin
versus S-1 only as adjuvant chemotherapy after curative distal gastrectomy in patients with
locally advanced gastric cancer.